SGX will offer Nifty options

Singapore Exchange has obtained licensing rights and expects to provide S&P CNX Nifty Index (Nifty) options and related products.

Licensing rights from India Index Services & Products Limited (IISL) will allow SGX to offer the product range including derivative contracts on the CNX Nifty Junior, CNX 100 and CNX Midcap indices. Subject to regulatory approvals, the products may be added amidst rise in the trading of India-related products on SGX.

Market participants are expected to gain enhanced means for risk management and increased trading opportunities with these new India-based products. Total trading volume in 2009 for the SGX S&P CNX Nifty Futures was 7.1 million contracts, or a daily average of 29,524 contracts.

SGX CEO Mr Magnus Bocker said, "We would like to express our appreciation to our customers for their support of our current suite of India-linked products. As we continue to find ways to meet customers' growing interest in the Indian market through our different partnerships, we are very excited to deepen our relationship with IISL with this planned expansion of our suite of Indian equity derivatives. This will complement our current offerings and bolster SGX's position as a one-stop gateway for international market participants to manage their Indian investment, trading and hedging needs."

Meanwhile Mr Ravi Narain, Chairman of the Board of Directors of IISL and Managing Director & CEO of the National Stock Exchange of India Limited, said, "The total trading volume of Nifty-linked Futures on NSE in 2009 was 167 million contracts, representing a daily average of 687,000 contracts and the trading volume of Nifty-linked Options on NSE in 2009 was 321 million contracts representing a daily average of 1,321,000 contracts Index derivatives based on Nifty have been very successful both in India and in Singapore over the last few years."

National Stock Exchange of India Limited and Singapore Exchange have also signed a Memorandum of Understanding to cooperate in the development of a market for India-linked products.

Join Singapore Business Review community
A NOTE FROM SINGAPORE BUSINESS REVIEW

The people you want to reach are already in this room.

Every quarter, SBR lands on the desks of the founders, CFOs, and directors running Asia's most consequential companies. Every day, they open our newsletter and read our website. It's a room that took twenty years to build — and it's the one most of our partners are trying to get into.

The good news is that the door is open. We work with companies on thought leadership articles, sponsored content, industry summits across Southeast Asia, regional awards programmes, podcasts, and media placements in print and digital. The shape of the right partnership depends on what you're trying to do, which is why we'd rather start with a conversation than send a rate card.


If you have something this room should know about, tell us. We'll tell you honestly whether we can help, and how.

No rate cards until we understand the brief. It's a better use of everyone's time.

Top News

Health ministry unveils homegrown AI model built for patients
It aims to address healthcare AI issues, which is mostly trained on the Western population.
Healthcare
Singapore and Hong Kong are partners in Chinese firms’ ASEAN push
Chinese companies use Hong Kong to raise capital and manage risk before expanding through Singapore into ASEAN.
Markets
AA REIT to buy Perth freehold industrial site for $38.43m
This adds a fully leased freehold asset with a 10-year lease and two renewal options.
Singapore pushes back against US biofuel scrutiny
The government maintained local output followed market demand as the US trade probe continues.